文献速递甲状腺疾病

甲巯咪唑停药期对Graves病中基于锝-99m甲状腺扫描估算碘-131摄取的影响

Effect of Methimazole Withdrawl Period on the I-131 Uptake Estimation Using Tc-99 m Thyroid Scanning in Graves' Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

本研究纳入116例拟行碘-131治疗的Graves病患者,按甲巯咪唑停药期(MWP)分组,评估不同停药期下基于锝-99m甲状腺摄取(99mTcTU)估算24小时放射性碘甲状腺摄取(131IU24h)的可行性与可靠性。结果显示,MWP≤两周时估算值与实测值相关性弱且一致性低,而MWP>两周至<一个月时相关性强(r=0.66,P=.002)且一致性最高(95%CI -15.86至15.52%)。结论认为,基于99mTcTU估算的131IU24h不适用于停药期小于两周的患者,需进一步前瞻性多中心研究验证。

要点

  • 停药期≤1周组131IU24h高于停药期>1周至≤2周组(70.22±7.95% vs 61.92±9.84%,P=.001)。
  • 标准组估算公式为:估算131IU24h=11.3ln(99mTcTU20min)+39.4(R²=0.62)。
  • 停药期>2周至<1个月组估算与实测131IU24h相关性强(r=0.66,P=.002)且一致性最高(95%CI -15.86至15.52%)。

核心结论

  • 基于99mTcTU估算的131IU24h不适用于本机构停药期小于两周的Graves病患者,需进一步前瞻性多中心研究验证。

研究设计与样本

  • 本研究纳入2022年4月至2023年4月在本院拟行碘-131治疗的116例Graves病患者。
  • 按甲巯咪唑停药期(MWP)分为标准组(未用甲巯咪唑或MWP>1个月)、MWP1组(MWP≤1周)、MWP2组(MWP>1周至≤2周)和MWP3组(MWP>2周至<1个月)。
  • 采用Fisher精确检验、单因素方差分析或Kruskal-Wallis检验比较变量,绘制标准组99mTcTU20min与131IU24h的拟合曲线,用线性关系和Bland-Altman图展示估算与实测131IU24h的关系和一致性。

主要发现

  • MWP1组131IU24h高于MWP2组(70.22±7.95% vs 61.92±9.84%,P=.001)。
  • MWP1组甲状腺质量大于MWP3组(36.15±22.38 g vs 21.25±11.90 g,P=.005)。
  • 标准组中131IU24h与99mTcTU20min的关系为:估算131IU24h=11.3ln(99mTcTU20min)+39.4(R²=0.62)。
  • 基于该算法,估算与实测131IU24h的相关性在MWP1和MWP2组均弱(均P>.05),在MWP3组强(r=0.66,P=.002)。
  • 估算与实测131IU24h的一致性在MWP3组最高(95%置信区间,-15.86至15.52%),优于MWP1和MWP2组。

临床怎么用

  • 作者认为,基于99mTcTU估算的131IU24h不适用于本机构停药期小于两周的Graves病患者。

局限性

  • 原文结论指出需进一步前瞻性多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The effect of methimazole withdrawal period (MWP) on the estimation of 24-hour-radioiodine thyroid uptake (131IU24h) from 99mTc-pertechnetate thyroid uptake (99mTcTU) remains unclear for patients with Graves' disease (GD). This study aims to investigate the feasibility and reliability of 99mTcTU-based 131IU24h estimation with different MWPs. METHODS: We enrolled 116 GD patients scheduled for 131I therapy at our hospital between April 2022 and April 2023. Based on MWP, the patients were categorized as standard (no methimazole or MWP > 1 month), MWP1 (MWP ≤ 1 week), MWP2 (MWP > 1 week to ≤2 weeks), and MWP3 (MWP > 2 weeks to <1 month). Fisher's exact test, one-way ANOVA, or Kruskal-Wallis test were used to compare variables. Fitted curves of 99mTcTU20min vs 131IU24h were plotted for the standard group. Linear relationships and Bland-Altman plots were used to illustrate the relationship and consistency between estimated and measured 131IU24h. RESULTS: 131IU24h was higher in the MWP1 group compared to MWP2 (70.22 ± 7.95% vs 61.92 ± 9.84%, P = .001), and thyroid mass was greater in the MWP1 group (36.15 ± 22.38 g) vs MWP3 (21.25 ± 11.90 g, P = .005). The relationship between 131IU24h and 99mTcTU20min in the standard group is described by the following algorithm: estimated 131IU24h = 11.3ln (99mTcTU20min) + 39.4 (R2 = 0.62). Based on it, the correlation between estimated and measured 131IU24h was weak in MWP1 and MWP2 (both P > .05) but strong in MWP3 (r = 0.66, P = .002). Additionally, the agreement between estimated and measured 131IU24h was highest in the MWP3 group (95% confidence interval, -15.86 to 15.52%) compared to the MWP1and MWP2 groups. CONCLUSION: Estimated 131IU24h based on 99mTcTU is not suitable for GD patients with MWP less than 2 weeks at our institution, necessitating further prospective multicenter studies for validation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wang H, Li W, Chang P, et al. Effect of Methimazole Withdrawl Period on the I-131 Uptake Estimation Using Tc-99 m Thyroid Scanning in Graves' Disease. J Clin Endocrinol Metab. 2025. PMID: 39523793. doi:10.1210/clinem/dgae794

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。